nile Antibody
nile Antibody
![]() Nile Red |
|||
B8209-100 | ApexBio | 100 mg | 170.4 EUR |
![]() Nile Red |
|||
B8209-50 | ApexBio | 50 mg | 150 EUR |
![]() Nile Red |
|||
B8209-500 | ApexBio | 500 mg | 254.4 EUR |
![]() Nile Red |
|||
HY-D0718 | MedChemExpress | 50mg | 148.8 EUR |
![]() Nile Red |
|||
GT2331-1G | Glentham Life Sciences | 1 g | 208.8 EUR |
![]() Nile Red |
|||
GT2331-250MG | Glentham Life Sciences | 250 mg | 104.4 EUR |
![]() West Nile virus antibody |
|||
10-1436 | Fitzgerald | 100 ug | 489.6 EUR |
Description: Mouse monoclonal West Nile virus antibody |
|||
![]() West Nile virus antibody |
|||
10-1437 | Fitzgerald | 100 ug | 489.6 EUR |
Description: Mouse monoclonal West Nile virus antibody |
|||
![]() West Nile Virus Matrix Antibody |
|||
3429-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: West Nile Virus Matrix Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. However, when the viruses are inside of infected cells, the matrix protein exists in its "pre-M" form as a heterodimer with the envelope proteins. Cleavage of the "pre-M" protein to its mature form occurs during release of the virus; this cleavage leas to the dissociation of the heterodimers. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
![]() West Nile Virus Matrix Antibody |
|||
3429-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: West Nile Virus Matrix Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. However, when the viruses are inside of infected cells, the matrix protein exists in its "pre-M" form as a heterodimer with the envelope proteins. Cleavage of the "pre-M" protein to its mature form occurs during release of the virus; this cleavage leas to the dissociation of the heterodimers. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
![]() West Nile Virus Matrix Antibody |
|||
3431-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: West Nile Virus Matrix Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. However, when the viruses are inside of infected cells, the matrix protein exists in its "pre-M" form as a heterodimer with the envelope proteins. Cleavage of the "pre-M" protein to its mature form occurs during release of the virus; this cleavage leas to the dissociation of the heterodimers. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
![]() West Nile Virus Matrix Antibody |
|||
3431-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: West Nile Virus Matrix Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. However, when the viruses are inside of infected cells, the matrix protein exists in its "pre-M" form as a heterodimer with the envelope proteins. Cleavage of the "pre-M" protein to its mature form occurs during release of the virus; this cleavage leas to the dissociation of the heterodimers. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
![]() West Nile Virus Core Antibody |
|||
3435-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: West Nile Virus Core Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins which play a major role for WNV entry into target cells. The viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway as delivery of core gene delivery into the striatum of mouse brain and skeletal muscle resulted in cell death and inflammation. |
|||
![]() West Nile Virus Core Antibody |
|||
3435-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: West Nile Virus Core Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins which play a major role for WNV entry into target cells. The viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway as delivery of core gene delivery into the striatum of mouse brain and skeletal muscle resulted in cell death and inflammation. |
|||
![]() West Nile Virus Envelope Antibody |
|||
3437-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
![]() West Nile Virus Envelope Antibody |
|||
3437-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
![]() West Nile Virus Envelope Antibody |
|||
3439-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
![]() West Nile Virus Envelope Antibody |
|||
3439-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
![]() West Nile Virus Envelope Antibody |
|||
3441-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
![]() West Nile Virus Envelope Antibody |
|||
3441-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
![]() West Nile Virus Matrix Antibody |
|||
24278-100ul | SAB | 100ul | 468 EUR |
![]() West Nile Virus Matrix Antibody |
|||
24279-100ul | SAB | 100ul | 468 EUR |
![]() West Nile Virus Core Antibody |
|||
24281-100ul | SAB | 100ul | 468 EUR |
![]() West Nile Virus Envelope Antibody |
|||
24282-100ul | SAB | 100ul | 468 EUR |
![]() West Nile Virus Envelope Antibody |
|||
24283-100ul | SAB | 100ul | 468 EUR |
![]() West Nile Virus Envelope Antibody |
|||
24284-100ul | SAB | 100ul | 468 EUR |
![]() West Nile Virus (WNV) Antibody |
|||
abx412023-01mg | Abbexa | 0.1 mg | 610.8 EUR |
![]() West Nile Virus Envelope Protein Antibody |
|||
abx022312-1mg | Abbexa | 1 mg | 1296 EUR |
![]() West Nile Virus Envelope Protein Antibody |
|||
abx022314-1mg | Abbexa | 1 mg | 1228.8 EUR |
![]() West Nile Virus Envelope Protein Antibody |
|||
abx022315-1mg | Abbexa | 1 mg | 1296 EUR |
![]() West Nile Virus Envelope Protein Antibody |
|||
abx022316-1mg | Abbexa | 1 mg | 1296 EUR |
![]() West Nile Virus Core Protein Antibody |
|||
abx023202-100ug | Abbexa | 100 ug | 811.2 EUR |
![]() Polyclonal West Nile Virus Core Antibody |
|||
AMM05447G | Leading Biology | 0.1 mg | 790.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human West Nile Virus Core . This antibody is tested and proven to work in the following applications: |
|||
![]() Polyclonal West Nile Virus Envelope Antibody |
|||
AMM05448G | Leading Biology | 0.1 mg | 790.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human West Nile Virus Envelope . This antibody is tested and proven to work in the following applications: |
|||
![]() Polyclonal West Nile Virus Envelope Antibody |
|||
AMM05449G | Leading Biology | 0.1 mg | 790.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human West Nile Virus Envelope . This antibody is tested and proven to work in the following applications: |
|||
![]() Polyclonal West Nile Virus Matrix Antibody |
|||
AMM05450G | Leading Biology | 0.1 mg | 790.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human West Nile Virus Matrix . This antibody is tested and proven to work in the following applications: |
|||
![]() Polyclonal West Nile Virus Envelope Antibody |
|||
APR11226G | Leading Biology | 0.1 mg | 790.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human West Nile Virus Envelope . This antibody is tested and proven to work in the following applications: |
|||
![]() Polyclonal West Nile Virus Matrix Antibody |
|||
APR11227G | Leading Biology | 0.1 mg | 790.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human West Nile Virus Matrix . This antibody is tested and proven to work in the following applications: |
|||
![]() Nile Blue A (sulfate) |
|||
HY-101900 | MedChemExpress | 10mM/1mL | 151.2 EUR |
![]() Nile Blue A chloride |
|||
59 | AAT Bioquest | 100 mg | 157 EUR |
![]() Mouse antibody for West Nile Virus Envelope |
|||
3655 | Virostat | 100 ug | 386.26 EUR |
Description: This is purified Mouse monoclonal antibody against West Nile Virus Envelope for WB, ELISA. |
|||
![]() Mouse antibody for West Nile Virus Envelope |
|||
3661 | Virostat | 100 ug | 386.26 EUR |
Description: This is purified Mouse monoclonal antibody against West Nile Virus Envelope for WB, ELISA. |
|||
![]() Mouse antibody for West Nile Virus Envelope |
|||
3671 | Virostat | 100 ug | 386.26 EUR |
Description: This is purified Mouse monoclonal antibody against West Nile Virus Envelope for WB, ELISA. |
|||
![]() Recombinant West Nile Envelope Virus |
|||
7-07960 | CHI Scientific | 100µg | Ask for price |
![]() Recombinant West Nile Envelope Virus |
|||
7-07961 | CHI Scientific | 500µg | Ask for price |
![]() Recombinant West Nile Envelope Virus |
|||
7-07962 | CHI Scientific | 1000µg | Ask for price |
![]() West Nile Virus Matrix Peptide |
|||
3429P | ProSci | 0.05 mg | 197.7 EUR |
Description: (IN) West Nile Virus Matrix peptide |
|||
![]() West Nile Virus Matrix Peptide |
|||
3431P | ProSci | 0.05 mg | 197.7 EUR |
Description: (CT) West Nile Virus Matrix peptide |
|||
![]() West Nile Virus Core Peptide |
|||
3435P | ProSci | 0.05 mg | 197.7 EUR |
Description: (CT) West Nile Virus Core peptide |
|||
![]() West Nile Virus Envelope Peptide |
|||
3437P | ProSci | 0.05 mg | 197.7 EUR |
Description: (IN) West Nile Virus Envelope peptide |
|||
![]() West Nile Virus Envelope Peptide |
|||
3439P | ProSci | 0.05 mg | 197.7 EUR |
Description: (NT) West Nile Virus Envelope peptide |
|||
![]() West Nile Virus Envelope Peptide |
|||
3441P | ProSci | 0.05 mg | 197.7 EUR |
Description: (IN) West Nile Virus Envelope peptide |
|||
![]() West Nile virus protein (Horse) |
|||
30-1261 | Fitzgerald | 250 ug | 548.4 EUR |
Description: Purified recombinant West Nile virus protein (Horse) |
|||
![]() West Nile Virus Envelope Protein |
|||
abx060680-100ug | Abbexa | 100 ug | 794.4 EUR |
![]() West Nile Envelope Virus Protein |
|||
20-abx260322 | Abbexa |
|
|
![]() West Nile Virus NS1 protein |
|||
80-1546 | Fitzgerald | 100 ug | 541.2 EUR |
Description: Purified Recombinant West Nile Virus NS1 protein (His tag) |
|||
![]() Native West Nile Virus antigen |
|||
DAGA-3052 | Creative Diagnostics | 1mg | 1279.2 EUR |
![]() Native West Nile Virus antigen |
|||
DAGA-3053 | Creative Diagnostics | 1mg | 1279.2 EUR |
![]() Nile Blue A (C.I. 51180) |
|||
GT3036-25G | Glentham Life Sciences | 25 g | 103.2 EUR |
![]() West nile virus PCR kit |
|||
PCR-VH054-48R | Bioingentech | 50T | 987.6 EUR |
![]() West nile virus PCR kit |
|||
PCR-VH054-96R | Bioingentech | 100T | 1335.6 EUR |
![]() West Nile Virus Envelope Recombinant Protein |
|||
53-361 | ProSci | 0.01 mg | 714.3 EUR |
Description: West Nile Virus Envelope Recombinant Protein |
|||
![]() Recombinant West Nile Pre-M Virus |
|||
7-07963 | CHI Scientific | 100µg | Ask for price |
![]() Recombinant West Nile Pre-M Virus |
|||
7-07964 | CHI Scientific | 500µg | Ask for price |
![]() Recombinant West Nile Pre-M Virus |
|||
7-07965 | CHI Scientific | 1000µg | Ask for price |
![]() West Nile Virus Envelope recombinant antigen |
|||
00401-V-01mg | Virogen | 0,1 mg | 321 EUR |
Description: West Nile Virus Envelope recombinant antigen-Immunodominant region |
|||
![]() West Nile Virus Envelope recombinant antigen |
|||
00401-V-1000ug | Virogen | 1000 ug | 1539 EUR |
Description: West Nile Virus Envelope recombinant antigen-Immunodominant region |
|||
![]() West Nile Virus ENV recombinant antigen |
|||
00403-V-01mg | Virogen | 0,1 mg | 321 EUR |
Description: West Nile Virus Envelope full length recombinant antigen 42 kDa region |
|||
![]() West Nile Virus ENV recombinant antigen |
|||
00403-V-1000ug | Virogen | 1000 ug | 1539 EUR |
Description: West Nile Virus Envelope full length recombinant antigen 42 kDa region |
|||
![]() Nile Red *CAS 7385-67-3* |
|||
22190 | AAT Bioquest | 25 mg | 138 EUR |
![]() West Nile Virus Pre-M Protein |
|||
abx060681-100ug | Abbexa | 100 ug | 794.4 EUR |
![]() West Nile Pre-M Virus Protein |
|||
20-abx260323 | Abbexa |
|
|